Company intelligence / Profile preview

Foundation Medical

Boston, Massachusetts, United Statesfoundationmedicalmn.com ↗

Ownership: Private
Employees: ~1100
Development stage: Other

Overview

Foundation Medicine provides FDA-approved comprehensive genomic profiling assays that help match cancer patients to targeted therapies and clinical trials. Their tests are widely used in oncology practice to inform personalized treatment decisions based on the molecular profile of individual tumors. The company has established itself as a leader in precision oncology diagnostics with robust partnerships across the biopharma sector.

Therapeutic areas: Oncology
Modalities: Diagnostic assay (Comprehensive genomic profiling)Diagnostic assay (liquid biopsy)
Industry: Molecular Diagnostics

Partnerships

Novartismultiple major pharmaceutical companies (>30 partnerships by 2018)Roche as parent/acquirerGuardant Health IP settlement/licensing agreement

Beyond the preview

Go deeper on Foundation Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foundation Medical.

Explore the full profile